F10, a new camptothecin derivative, was identified as a new orally–bioavailable, potent antitumor agent

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
F10, a new camptothecin derivative, was identified as a new orally–bioavailable, potent antitumor agent
Authors
Keywords
Drug design, Camptothecin derivatives, Antitumor agent, Antitumor effect, Acute toxicity
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 202, Issue -, Pages 112528
Publisher
Elsevier BV
Online
2020-07-05
DOI
10.1016/j.ejmech.2020.112528

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.